Simvastatin Attenuates Intestinal Fibrosis Independent of the Anti-Inflammatory Effect by Promoting Fibroblast/Myofibroblast Apoptosis in the Regeneration/Healing Process from TNBS-Induced Colitis
Authors:
- 11 September 2011
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 57 (2) , 335-344
Abstract
Intestinal deformity and stenosis are induced by fibrosis during the process healing of intestinal chronic inflammation in inflammatory bowel disease (IBD). Potent anti-inflammatory treatment of patients with Crohn’s disease (CD) may induce fibrous stenosis, and this is often difficult to treat in clinical practice. Therefore, it is necessary to develop a treatment strategy that concomitantly exhibits repair/regenerative and anti-fibrotic effects, in addition to the current anti-inflammatory effect, for the treatment of inflammatory bowel diseases. However, the relationship between the course of inflammatory activity and the healing process and fibrogenesis has not been elucidated; although the complex involvement of various factors in the mechanism of biological fibrosis has been investigated. Simvastatin (SIMV), an HMG-CoA reductase inhibitor, exhibits anti-inflammatory and anti-fibrotic effects. The current study established a model of the regeneration/healing process from TNBS-induced colitis and investigated the anti-inflammatory and anti-fibrotic effects of SIMV.Keywords
This publication has 39 references indexed in Scilit:
- Wound healing and fibrosis in intestinal diseaseGut, 2006
- Expression and regulation of connective tissue growth factor by transforming growth factor β and tumour necrosis factor α in fibroblasts isolated from strictures in patients with Crohn's diseaseBritish Journal of Surgery, 2006
- Review article: infliximab therapy for inflammatory bowel disease – seven years onAlimentary Pharmacology & Therapeutics, 2006
- Increased vascular endothelial growth factor production in fibroblasts isolated from strictures in patients with Crohn's diseaseBritish Journal of Surgery, 2004
- Statins differ in their ability to block NF-kB activation in human blood monocytesInt. Journal of Clinical Pharmacology and Therapeutics, 2003
- Oxazolone Colitis, a Th2 Colitis Model Resembling Ulcerative Colitis, Is Mediated by IL-13-Producing NK-T CellsImmunity, 2002
- Myofibroblasts and mechano-regulation of connective tissue remodellingNature Reviews Molecular Cell Biology, 2002
- Antibodies to interleukin 12 abrogate established experimental colitis in mice.Journal of Experimental Medicine, 1995
- Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblastsJournal of Cell Biology, 1993
- Regulation of the mevalonate pathwayNature, 1990